Invention Grant
- Patent Title: Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
-
Application No.: US15564348Application Date: 2016-04-14
-
Publication No.: US10335388B2Publication Date: 2019-07-02
- Inventor: John A. Josey , Eli M. Wallace , Guangzhou Han
- Applicant: PELOTON THERAPEUTICS, INC.
- Applicant Address: US TX Dallas
- Assignee: PELOTON THERAPEUTICS, INC.
- Current Assignee: PELOTON THERAPEUTICS, INC.
- Current Assignee Address: US TX Dallas
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2016/027611 WO 20160414
- International Announcement: WO2016/168510 WO 20161020
- Main IPC: A61K31/277
- IPC: A61K31/277 ; A61K45/06 ; A61K31/435 ; A61P35/00
Abstract:
The present invention provides methods and pharmaceutical compositions for treating proliferative disorders. The method involves step of administering to said subject a HIF-2alpha inhibitor and an immunotherapeutic agent.
Public/Granted literature
- US20180140569A1 COMBINATION THERAPY OF A HIF-2-ALPHA INHIBITOR AND AN IMMUNOTHERAPEUTIC AGENT AND USES THEREOF Public/Granted day:2018-05-24
Information query
